|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| C07K 16/30 | |||
| A61P 35/00 | |||
| A61K 47/48 | |||
| A61K 39/395 |
| (11) | Patento numeris | 2240516 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08865592.3 |
| Europos patento paraiškos padavimo data | 2008-12-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-10-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-07-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2008/068270 |
| Data | 2008-12-23 |
| (87) | Numeris | WO 2009/080832 |
| Data | 2009-07-02 |
| (30) | Numeris | Data | Šalis |
| 16614 P | 2007-12-26 | US | |
| 87590 P | 2008-08-08 | US | |
| 87466 P | 2008-08-08 | US |
| (72) |
DAELKEN, Benjamin, DE
UHEREK, Christoph, DE
ANDERSON, Kenneth, US
HIDESHIMA, Teru, US
BRUECHER, Christoph, DE
OSTERROTH, Frank, DE
AIGNER, Silke, DE
GERMER, Matthias, DE
|
| (73) |
Biotest AG,
Landsteinerstr. 5, 63303 Dreieich,
DE
Immunogen, Inc., 830 Winter Street, Waltham, MA 02451-1477, US Dana-Farber Cancer Institute, Inc., 450 Brookline Avenue, Boston, MA 02215-5450, US |
| (54) | METHODS AND AGENTS FOR IMPROVING TARGETING OF CD138 EXPRESSING TUMOR CELLS |
| METHODS AND AGENTS FOR IMPROVING TARGETING OF CD138 EXPRESSING TUMOR CELLS |